Temporal and dietary fat content-dependent islet adaptation to high-fat feeding-induced glucose intolerance in mice

Metabolism: Clinical and Experimental

Volumn 56, Issue 1, 2007, Pages 122-128

  Winzell, Maria Sörhede ^a   Magnusson, Caroline ^a   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CONTROLLED STUDY; DRUG ELIMINATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESPONSE; LIPID DIET; MOUSE; NONHUMAN; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PRIORITY JOURNAL; TIME; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BIOPSY; BLOOD GLUCOSE; BODY COMPOSITION; BODY WEIGHT; DIETARY FATS; ENERGY METABOLISM; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; LIVER; MICE; MICE, INBRED C57BL; TRIGLYCERIDES;

EID: 33845189881     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.09.008     Document Type: Article

References (35)

1. Kahn S.E. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46 (2003) 3-19
2. Bergman R.N. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38 (1989) 1512-1527
3. Larsson H., and Ahrén B. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance. Diabetologia 39 (1996) 1099-1107
4. Kahn S.E. Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86 (2001) 4047-4058
5. Kahn S.E., Prigeon R.L., McCulloch D.K., et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 4 (1993) 1663-1672
6. Segal-Isaacson C.J., Carello E., and Wylie-Rosett J. Dietary fats and diabetes mellitus: is there a good fat?. Curr Diabetes Rep 1 (2001) 161-169
7. Howard B.V. Dietary fat as a risk factor for type 2 diabetes. Ann NY Acad Sci 967 (2002) 324-328
8. Stumvoll M., Goldstein B.J., and van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 (2005) 1333-1346
9. Golay A., and Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab 19 (2005) 649-663
10. Zraika S., Dunlop M., Proietto J., et al. Effects of free fatty acids on insulin secretion in obesity. Obes Rev 3 (2002) 103-112
11. Boden G., and Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction. Eur J Clin Invest 32 (2002) 14-23
12. Boden G., and Laakso M. Lipids and glucose in type 2 diabetes: what is the cause and effect?. Diabetes Care 27 (2004) 2253-2259
13. Surwit R.S., Kuhn C.M., Cochrane C., et al. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37 (1988) 1163-1167
14. Winzell M.S., and Ahrén B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (2004) S215-S219
15. Pacini G., Thomaseth K., and Ahrén B. Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab 281 (2001) E693-E703
16. Ahrén B., and Pacini G. Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. Am J Physiol Endocrinol Metab 283 (2002) E738-E744
17. Ahrén B., and Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies. Eur J Endocrinol 150 (2004) 97-104
18. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc Assoc Am Physicians 111 (1999) 241-248
19. Storlien L.H., Baur L.A., Kriketos A.D., et al. Dietary fats and insulin action. Diabetologia 39 (1996) 621-631
20. Thanopoulou A.C., Karamanos B.G., Angelico F.V., et al. Dietary fat intake as risk factor for the development of diabetes: multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD). Diabetes Care 26 (2003) 302-307
21. Pan D.A., Lillioja S., Milner M.R., et al. Skeletal muscle membrane lipid composition is related to adiposity and insulin action. J Clin Invest 96 (1995) 2802-2808
22. Storlien L.H., Jenkins A.B., Chisholm D.J., et al. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40 (1991) 280-289
23. Borkman M., Storlien L.H., Pan D.A., et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 328 (1993) 238-244
24. Warnotte C., Gilon P., Nenquin M., et al. Mechanisms of the stimulation of insulin release by saturated fatty acids. A study of palmitate effects in mouse beta-cells. Diabetes 43 (1994) 703-711
25. Robertson R.P., Harmon J., Tran P.O., et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53 (2004) S119-S124
26. Lee Y., Hirose H., Ohneda M., et al. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91 (1994) 10878-10882
27. Ahrén B. Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand 171 (2001) 161-167
28. De Fronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15 (1992) 318-368
29. Postic C., Dentin R., and Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 30 (2004) 398-408
30. Carpentier J.L. Insulin receptor internalization: molecular mechanisms and physiopathological implications. Diabetologia 37 (1994) S117-S124
31. Duckworth W.C., Hamel F.G., and Peavy D.E. Hepatic metabolism of insulin. Am J Med 85 (1988) 71-76
32. Goto T., Onuma T., Takebe K., et al. The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19 (1995) 841-845
33. Schaffer J.E. Lipotoxicity: when tissues overeat. Curr Opin Lipidol 14 (2003) 281-287
34. Pietilainen K.H., Rissanen A., Kaprio J., et al. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins. Am J Physiol Endocrinol Metab 288 (2005) E768-E774
35. Petersen K.F., Dufour S., Befroy D., et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54 (2005) 603-608